HomeMarket Intelligence & PolicyAustralian Cannabis Policy & LawVirginia Adult-Use Cannabis Market Stalls as Lawmakers Reject Governor's Amendments

Virginia Adult-Use Cannabis Market Stalls as Lawmakers Reject Governor’s Amendments

Legislative Impasse Halts Virginia Adult-Use Cannabis Market Progress

Five years after Virginia legalized simple adult possession of cannabis, the establishment of a regulated retail market remains at an impasse. The Virginia General Assembly recently rejected over 40 proposed changes by Governor Abigail Spanberger to House Bill 642 and Senate Bill 542, companion measures intended to launch the state’s as reported by Marijuana Moment, which originally cited the Virginia Mercury. This decision sends the legislation back to the Governor, who now faces a binary choice: sign the original proposal or veto it, potentially prolonging the state’s legal gray area where possession is permitted but legal purchase is not possible.

Governor Spanberger’s proposed substitute legislation, which frustrated many lawmakers and stakeholders, sought to delay the start of retail sales to July 1, 2027. Her amendments aimed to restructure significant portions of the framework negotiated by lawmakers during the session, with regulators beginning to accept license applications by September 1, 2026, ahead of an early 2027 license issuance.

Governor’s Proposed Regulatory Shifts and Penalties

The core of the dispute centered on Governor Spanberger’s attempt to rewrite substantial parts of the bills. Her proposed changes would have fundamentally altered the structure of Virginia’s adult-use cannabis market:

  • Regulatory Authority Shift: Instead of embedding detailed licensing rules in state law, the substitute would have directed the Virginia Cannabis Control Authority to establish these rules through regulations.
  • License Reduction: The number of retail licenses would have been reduced from 350 to 200, with this cap extended until January 1, 2029.
  • Oversight Restructuring: Legislative appointments to the Cannabis Control Authority board would have been eliminated, making all members gubernatorial appointees and reducing required agricultural representation.
  • Stripped Provisions: Elements such as the Cannabis Equity Reinvestment Fund, authority for the governor to negotiate tribal government agreements, and a requirement for the Alcoholic Beverage Control Authority to operate an illegal activity tip line would have been removed.
  • Tax Revenue Allocation: Fixed percentage allocations for cannabis tax revenue would have been eliminated, directing lawmakers to allocate funds through the state budget for priorities like public health and education. The state tax rate would have been set at 6 percent until July 2029, rising to 8 percent thereafter.
  • Increased Penalties: Public consumption would have become a Class 4 misdemeanor, and underage possession a Class 1 misdemeanor. The personal possession limit would have been reduced from 2.5 ounces to 2 ounces.
  • Hemp Regulation Delay: The elimination of the state’s 25:1 hemp ratio, a standard for distinguishing legal hemp products from marijuana based on THC concentration, would have been delayed until November 2026. This builds on previous regulatory actions in Virginia concerning hemp-derived products, as reported by Hemp Gazette.

Governor Spanberger stated these changes were necessary to strengthen enforcement and public safety, particularly in addressing the illicit market and unregulated products.

Lawmakers’ Rejection and Industry Reactions

Del. Paul Krizek (D-Fairfax), sponsor of House Bill 642, indicated that the Governor’s modifications went too far, stating they were contrary to where lawmakers had arrived through the legislative process.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.

Steven Gothrinet
Steven Gothrinet has been part of the Hemp Gazette in-house reporting team since 2015. Steven's broad interest in cannabis was initially fueled by the realisation of industrial hemp's versatility across multiple sectors. You can contact Steve here.
RELATED ARTICLES

Most Popular